Meitheal Pharmaceuticals (Meitheal) is pleased to announce the official launch of Propofol Injectable Emulsion, USP:
- 71288-729-21 – Propofol Injectable Emulsion, USP 200 mg per 20 mL SDV
- 71288-730-51 – Propofol Injectable Emulsion, USP 500 mg per 50 mL SDV
- 71288-731-53 – Propofol Injectable Emulsion, USP 1,000 mg per 100 mL SDV
ABOUT PROPOFOL INJECTABLE EMULSION, USP
Propofol Injectable Emulsion, USP is an intravenous general anesthetic and sedation drug indicated for:
- Induction of General Anesthesia for Patients Greater than or Equal to 3 Years of Age
- Maintenance of General Anesthesia for Patients Greater than or Equal to 2 Months of Age
- Initiation and Maintenance of Monitored Anesthesia Care (MAC) Sedation in Adult Patients
- Sedation for Adult Patients in Combination with Regional Anesthesia
- Intensive Care Unit (ICU) Sedation of Intubated, Mechanically Ventilated Adult Patients
For full prescribing information, please click on the following link.
Learn more about who we are and what we do at: www.meithealpharma.com.
